Evolution of dyslipidemia: from etiological mechanisms to new targets of personalized preventive nutraceutical therapy with red yeast rice
The review presents an analysis of studies on the role of armolipid in the primary prevention of cardiovascular diseases. Armolipid is the nutraceutical that combines the lipid-lowering components of red yeast rice (monocalin K, policosanol) and antioxidants (coenzyme Q, astaxanthin and folic acid)....
Main Authors: | O. Sh. Oinotkinova, E. L. Nikonov, E. V. Kryukov, A. P. Baranov, M. I. Voevoda |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
2019-12-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2440 |
Similar Items
-
Hypolipaemic nutraceutics: red yeast rice and Armolipid, berberine and bergamot
by: Longina Kłosiewicz-Latoszek, et al.
Published: (2021-03-01) -
Beneficial Effects of a Nutraceutical Combination on Lipid Profiles in Children with Moderate and Severe Hypercholesterolemia
by: Anastasia Garoufi, et al.
Published: (2024-12-01) -
The Role of Red Yeast Rice Based Preparations for Non-Pharmacological Correction of Dyslipidemia in Patients with Low and Moderate Cardiovascular Risk (Expert Opinion)
by: M. V. Ezhov, et al.
Published: (2020-03-01) -
Red yeast rice preparations for dyslipidemia: An overview of systematic reviews and network meta-analysis
by: Fangfang Zhao, et al.
Published: (2023-05-01) -
The Lipid-Lowering Efficacy of a Nutraceutical Combination Including Leucoselect Phytosome, Red Yeast Rice, Policosanol and Folic Acid in Dyslipidaemia Patients: Real-World Insights
by: Vincenzo Russo, et al.
Published: (2024-03-01)